MedTrace Logo

Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease - EU

NCT07708675 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-07-16

No results posted yet for this study

Summary

The objective of this study is to evaluate the safety and feasibility of the Symani System and microsurgical techniques in the deep Cervical Lymph Node (dCLN) region in patients with confirmed Alzheimer's disease.

Conditions

Interventions

DEVICE

Symani Surgical System

Use of Symani Surgical System for performing microsurgical techniques in the deep cervical lymph nodes.

Sponsors & Collaborators

  • MMI (Medical Microinstruments, Inc.)

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-01
Primary Completion
2028-04-01
Completion
2029-03-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07708675 on ClinicalTrials.gov